CELESTICA INC (CLS) Market Cap & Valuation Ratios
CELESTICA INC (CLS) has a market cap of $29.9B, a trailing P/E of 27.1 and a price-to-sales ratio of 1.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLSCELESTICA INCFollow CLS — free
—
Price chart with a free account
- Market cap
- 29.9B
- P/E TTM
- 27.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Peers
electronic components · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CLS | 30 | 27.1 | 1.9 | 19.5 | 1.7% | +47% | 9% | 46% |
| GLW | 107 | 56.5 | 6.6 | 27.9 | 2.2% | +19% | 15% | 13% |
| TEL | 60 | 20.4 | 3.3 | 13.4 | 5.5% | +17% | 20% | 17% |
| FLEX | 28 | 29.6 | 1.0 | 15.5 | 2.9% | +12% | 5% | 16% |
| JBL | 28 | 28.1 | 0.8 | 12.5 | 4.9% | +21% | 5% | 44% |
| FN | 11 | 24.1 | 2.2 | 19.6 | 0.0% | +36% | 10% | 21% |
| LFUS | 8.9 | — | 3.4 | 38.3 | 5.0% | +15% | 4% | 3% |
| TTMI | 8.4 | 36.2 | 2.6 | 18.3 | -0.2% | +28% | 10% | 13% |
| SANM | 8.3 | 27.9 | 0.7 | 12.5 | 7.1% | +59% | 4% | 15% |
| VICR | 8.1 | 56.2 | 16.2 | 70.0 | 0.6% | +12% | 19% | 21% |
| RAL | 7.4 | — | 3.8 | — | 4.5% | +6% | -53% | -36% |
| Median of these 10 | 28.8 | 3.0 | 18.3 | 3.7% | +18% | 7% | 16% |
P/E 27.1 vs. a peer median of 28.8; EV/Sales 1.9 vs. 3.0. CLS's own P/E sits at the 21st percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesLFUS and RAL have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
CELESTICA INC — questions
- What is CELESTICA INC's market cap?
- $29.9B.
- What is CELESTICA INC's P/E ratio?
- 27.1 on trailing twelve-month earnings to 2026-06-30.
- What is CELESTICA INC's price-to-sales ratio?
- 1.9.
Every figure on this page comes from CELESTICA INC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.